![Pharmaceutics | Free Full-Text | Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler Pharmaceutics | Free Full-Text | Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-01528/article_deploy/html/images/pharmaceutics-13-01528-g001.png)
Pharmaceutics | Free Full-Text | Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler
![Tobramycin (TOBI® or TOBI PODHALER®) in ventilator associated pneumonia: an overviewm by Shira michael - Issuu Tobramycin (TOBI® or TOBI PODHALER®) in ventilator associated pneumonia: an overviewm by Shira michael - Issuu](https://image.isu.pub/180927045007-615548bb5c012acc4a8b23c23077e9d0/jpg/page_1.jpg)
Tobramycin (TOBI® or TOBI PODHALER®) in ventilator associated pneumonia: an overviewm by Shira michael - Issuu
![FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US | Fierce Pharma FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/OZEMPIC2.jpg?VersionId=q.L1sWRGiHcHLxxysDKFYspYgame.z2q)
FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US | Fierce Pharma
![Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence - Kamal Hamed, Laurie Debonnett, 2017 Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence - Kamal Hamed, Laurie Debonnett, 2017](https://journals.sagepub.com/cms/10.1177/1753465817691239/asset/images/large/10.1177_1753465817691239-fig1.jpeg)
Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence - Kamal Hamed, Laurie Debonnett, 2017
![The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis - ScienceDirect The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517316302848-fx1.jpg)